Priorix (measles, mumps and rubella vaccine, live) is indicated for active immunization for the prevention of measles, mumps and rubella in individuals aged 12 months old and older.
Parata provides BD access to a new $600 million pharmacy automation market segment that is expected to grow approximately 10% annually to $1.5 billion in the United States alone over 10 years, according to the company.